Akèy › Kansè Ipofaringe › Illinois › Springfield
Etid klinik pou Kansè Ipofaringe nan Springfield, IL
3 etid pou Kansè Ipofaringe ap chèche patisipan nan sit nan ak bò kote Springfield (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Ap rekriteFaz 3
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Ap rekriteFaz 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Etid Kansè Ipofaringe nan lòt vil
- Atlanta, GA6 etid
- Chicago, IL6 etid
- Kansas City, MO5 etid
- Richmond, VA5 etid
- Wausau, WI5 etid
- Bloomington, IL5 etid
- Stevens Point, WI5 etid
- Cape Girardeau, MO5 etid
- Peoria, IL5 etid
- Milwaukee, WI5 etid
- Joliet, IL5 etid
- Overland Park, KS4 etid
Lòt etid nan Springfield
- Kansè Poumon ki pa ti selil13 etid
- Kansè poumon12 etid
- Kansè kolorektal9 etid
- Kansè nan tete8 etid
- Leksemi mieloïd egi8 etid
- Kansè (tout kalite)6 etid
- Kansè vejik6 etid
- Kansè pwostat6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè renn (Kasinom selil renn)6 etid
- Kansè pankreyas5 etid
- Melanom5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.